Buy Memantine

A remedy for the treatment of dementia. It is a noncompetitive antagonist of glutamate NMDA-receptors (including in black substance), thereby reducing the excessive stimulating effect of cortical glutamate neurons on neostriatum, which develops against the background of insufficient dopamine excretion. Reducing the entry of Ca2 + into neurons, reduces the possibility of their destruction.

Has nootropic, cerebrozodilating, antihypoxic and psychostimulating action.

Improves weakened memory, increases the ability to concentrate, reduces fatigue and symptoms of depression, reduces spasticity of skeletal muscles, caused by diseases or brain damage.

Dementia of moderate and severe degree in Alzheimer's disease.

When administered orally, the initial dose for adults is 5 mg / day. In the future, the dose can be increased weekly by 5 mg. The average maintenance dose is 10-20 mg / day. The maximum dose is 20 mg / day.